Small interfering RNA therapy in cancer: mechanism, potential targets, and clinical applications
Author:
Publisher
Informa Healthcare
Subject
Clinical Biochemistry,Drug Discovery,Pharmacology,Molecular Medicine
Link
http://www.tandfonline.com/doi/pdf/10.1517/14728222.12.5.637
Reference80 articles.
1. Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells
2. RNA interference is mediated by 21- and 22-nucleotide RNAs
3. Applications of RNA Interference in Mammalian Systems
4. RNAi Screening for Therapeutic Targets in Human Malignancies
5. RNA Interference as Potential Therapy — Not So Fast
Cited by 115 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Polymer-lipid hybrid nanomedicines to deliver siRNA in and against glioblastoma cells;International Journal of Pharmaceutics;2024-04
2. Combination of B7H6-siRNA and temozolomide synergistically reduces stemness and migration properties of glioblastoma cancer cells;Experimental Cell Research;2023-08
3. A critical review of novel antibiotic resistance prevention approaches with a focus on postbiotics;Critical Reviews in Food Science and Nutrition;2023-05-19
4. Combination of SIX4-siRNA and temozolomide inhibits the growth and migration of A-172 glioblastoma cancer cells;Naunyn-Schmiedeberg's Archives of Pharmacology;2023-04-24
5. Modified Linear Peptides Effectively Silence STAT-3 in Breast Cancer and Ovarian Cancer Cell Lines;Pharmaceutics;2023-02-16
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3